Summit Therapeutics Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC SMMT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

892,629

Value ($000)

15,612

Weight

0.0%

2021 Q2 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	15,612	0.0%	892,629	12/31/2025
2025 Q3	11/10/2025	18,106	0.0%	876,390	9/30/2025
2025 Q2	8/12/2025	27,487	0.0%	1,291,671	6/30/2025
2025 Q1	9/15/2025	28,177	0.0%	1,460,717	3/31/2025
2024 Q4	2/6/2025	26,501	0.0%	1,485,072	12/31/2024
2024 Q3	11/12/2024	31,376	0.0%	1,432,713	9/30/2024
2024 Q2	8/12/2024	7,291	0.0%	934,729	6/30/2024
2024 Q1	5/9/2024	4,208	0.0%	1,016,545	3/31/2024
2023 Q4	2/6/2024	2,490	0.0%	953,846	12/31/2023
2023 Q3	11/8/2023	1,759	0.0%	940,796	9/30/2023
2023 Q2	8/10/2023	781	0.0%	311,070	6/30/2023
2023 Q1	5/12/2023	26	0.0%	14,581	3/31/2023
2022 Q4	2/13/2023	64	0.0%	15,112	12/31/2022
2022 Q1	5/13/2022	151	0.0%	61,313	3/31/2022
2021 Q4	2/11/2022	149	0.0%	55,033	12/31/2021
2021 Q3	11/16/2021	276	0.0%	55,033	9/30/2021
2021 Q2	8/16/2021	356	0.0%	47,648	6/30/2021